Injectable compositions
AssigneeAshmont Holdings Limited
InventorColin Manson Harvey
Life of this patent
Estimating the term…
Abstract
A stable injectable composition includes a non-aqueous parasitic agent in a therapeutically effect amount, chosen from the group of avermectin, ivermectin, doramectin, abamectin, milbemycin and moxidecting, and an antigen in combination with a liquid carrier that also acts as an adjuvant for use with warm blooded animals and a method for treating parasitic diseases and preventing bacterial and viral diseases in warm blooded animals.
Claims13
A method of treating parasitic, bacterial, or viral diseases in warm blooded animals by administering to an animal a composition consisting essentially of:
- a non-aqueous compound present in a therapeutically effective amount, selected from the group consisting of milbemycins and avermectins compounds;
- an antigen in combination with a liquid carrier that also acts as an adjuvant for use with the warm-blooded animals, wherein said carrier is selected from the group consisting of vegetable, mineral oils and combinations thereof;
- and
- an oil soluble solvent.
A stable injectable composition suitable for the treatment of warm-blooded animals consisting essentially of:
- a non-aqueous compound present in a therapeutically effective amount, selected from the group consisting of milbemycins and avermectins compounds;
- an antigen in combination with a liquid carrier that also acts as an adjuvant for use with the warm-blooded animals, the carrier selected from the group consisting of vegetable, mineral oils and combinations thereof;
- and
- an oil soluble solvent.
Dependencies are inferred from the claim text.